Literature DB >> 18634160

Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans.

Ritu Khurana1, Robert Wolf, Steven Berney, Gloria Caldito, Samina Hayat, Seth Mark Berney.   

Abstract

OBJECTIVE: To investigate the occurrence of lung cancer in patients with rheumatoid arthritis (RA) in the US veteran population. Patients with rheumatic diseases appear to have an increased risk for the development of lymphoproliferative and some solid organ malignancies.
METHODS: We conducted a retrospective case control study using prospectively collected data from the Veterans Integrated Service Networks (VISN) 16 Veteran Affairs (VA) database from 1998 to 2004. We studied the association of RA and lung cancer and analyzed data on 483,721 VA patients. Patients were identified by searching for the diagnoses of RA and lung cancer based on the International Classification of Diseases (ICD) codes. We identified 8768 (1.81%) patients with a diagnosis of RA (ICD code 714.0), 7280 (1.5%) patients with lung cancer (ICD code 162.0), 247 patients with lung cancer and RA, and 7033 patients with lung cancer but no RA. Logistic regression analysis was performed to adjust for age, gender, race, and tobacco and asbestos exposure. Statistical tests were conducted at a 5% level of significance.
RESULTS: The diagnosis of RA was determined to have a significant association with lung cancer in this veteran population. Patients with RA are 43% (odds ratio 1.43) more likely to develop lung cancer than patients without RA, when adjusted for covariates.
CONCLUSION: Our study shows a significant positive association between RA and the development of lung cancer in the veteran population. Veterans with RA have an increased incidence of lung cancer when compared to the non-RA population.

Entities:  

Mesh:

Year:  2008        PMID: 18634160

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  23 in total

1.  Occurrence of pulmonary rheumatoid nodules following biological therapies.

Authors:  Attila Kovács; Beáta Baksay; Anita Cserenyecz; Klára Molnár; Mária Takács; Zoltán Szekanecz
Journal:  Clin Rheumatol       Date:  2014-09-30       Impact factor: 2.980

Review 2.  Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.

Authors:  Alla Ishchenko; Rik J Lories
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

Review 3.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393

4.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

Review 5.  Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.

Authors:  Alexis L Franks; Jill E Slansky
Journal:  Anticancer Res       Date:  2012-04       Impact factor: 2.480

6.  Use of US Veterans Affairs administrative databases to study outcomes in patients with rheumatoid arthritis.

Authors:  Prabha Ranganathan; Angelique L Zeringue; Jay R McDonald
Journal:  J Rheumatol       Date:  2009-05       Impact factor: 4.666

7.  Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions.

Authors:  Lori C Sakoda; Louise M Henderson; Tanner J Caverly; Karen J Wernli; Hormuzd A Katki
Journal:  Curr Epidemiol Rep       Date:  2017-10-24

Review 8.  Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse.

Authors:  Saeed H Manjili; Madison Isbell; Negar Ghochaghi; Tyler Perkinson; Masoud H Manjili
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 15.707

9.  Malignancy validation in a United States registry of rheumatoid arthritis patients.

Authors:  Mark C Fisher; Victoria Furer; Marc C Hochberg; Jeffrey D Greenberg; Joel M Kremer; Jeff R Curtis; George Reed; Leslie Harrold; Daniel H Solomon
Journal:  BMC Musculoskelet Disord       Date:  2012-05-31       Impact factor: 2.362

10.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.